A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
Titel:
A phase II trial to assess efficacy and safety of afatinib in extensively pretreated patients with HER2-negative metastatic breast cancer
Auteur:
Schuler, Martin Awada, Ahmad Harter, Philipp Canon, Jean Luc Possinger, Kurt Schmidt, Marcus Grève, Jacques De Neven, Patrick Dirix, Luc Jonat, Walter Beckmann, Matthias W. Schütte, Jochen Fasching, Peter A. Gottschalk, Nina Besse-Hammer, Tatiana Fleischer, Frank Wind, Sven Uttenreuther-Fischer, Martina Piccart, Martine Harbeck, Nadia